1
/
of
0
FDA Drug/Biologics Approval BLA 103976 S-5211, OMALIZUMAB
FDA Drug/Biologics Approval BLA 103976 S-5211, OMALIZUMAB
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
BLA 103976 S-5211
Company: GENENTECH
Drug Name: XOLAIR
Active Ingredients: OMALIZUMAB
Strength: 300MG/2ML
Dosage Form/Route: SYRINGE
Action Date: 06/20/2003
Marketing Status: Prescription
Submission Classification: ORIG-1
Company: GENENTECH
Drug Name: XOLAIR
Active Ingredients: OMALIZUMAB
Strength: 300MG/2ML
Dosage Form/Route: SYRINGE
Action Date: 06/20/2003
Marketing Status: Prescription
Submission Classification: ORIG-1
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details